Focus: NuVasive is a mid-cap medical device company headquartered in San Diego, CA, with 5,001–10,000 employees specializing in spine surgery solutions and orthopedic devices. The company is publicly traded (GMED) and serves the surgical intervention market for degenerative spinal conditions and musculoskeletal disorders.
Profile data last refreshed 13h ago · AI intelligence enriched 2w ago
Hot — 934 jobs added in 30d
Net +847 (934 new, 87 removed). Aggressive expansion phase.
Best fit for engineers, clinical ops professionals, and commercial leaders seeking stable orthopedic device careers; poor fit for drug discovery scientists or early-stage pipeline exposure.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for NuVasive
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from NuVasive's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles